top of page

USPSTF updates recommendations on risk-reducing breast cancer medication

  • Writer: Care For A Cure
    Care For A Cure
  • Sep 6, 2019
  • 1 min read

Healthcare providers should offer risk-reducing medications such as tamoxifen, raloxifene and aromatase inhibitors to women at an increased risk of breast cancer or low risk of experiencing adverse effects, according to the U.S. Preventive Services Task Force (USPSTF). The full recommendation statement was published by JAMA.

Comments


Featured Posts
Recent Posts
Archive
Search By Tags
bottom of page